Related Experiment Video
Updated: Jul 7, 2026
06:47
Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
Published on: January 28, 2021
[Gene-diet interactions in atherogenic dyslipidemias (part 1)]
Casopis Lekaru Ceskych
|February 9, 2008
Summary
This review explores how gene variations, like single nucleotide polymorphisms, affect lipid metabolism and cardiovascular risk in response to diet. Understanding these genetic interactions is key for personalized nutrition and preventing heart disease.
Area of Science:
- Molecular genetics
- Nutritional science
- Cardiovascular research
Context:
- Advances in molecular genetics have spurred investigation into lipid-related gene polymorphisms.
- Nutrigenetics and nutrigenomics offer new frameworks for understanding gene-diet interactions.
- Cardiovascular disease remains a major health concern, necessitating research into its underlying mechanisms.
Purpose:
- To review current knowledge on common polymorphisms in genes related to lipid metabolism and cardiovascular risk.
- To examine the role of gene-diet interactions in modulating metabolic effects.
- To highlight the need for research into complex interrelationships between multiple gene variants.
Summary:
- This review synthesizes findings on functional polymorphisms in genes encoding apolipoproteins, transfer proteins, cell receptors, and enzymes.
- It discusses how these genetic variations influence lipid metabolism and potentially cardiovascular risk.
- The review notes a predominant focus on single nucleotide polymorphisms and individual nutrients, with limited exploration of multiple gene interactions.
Impact:
- Provides a comprehensive overview of genetic factors influencing lipid metabolism and cardiovascular health.
- Highlights the emerging fields of nutrigenetics and nutrigenomics for personalized nutrition.
- Identifies research gaps in understanding complex gene-gene and gene-diet interactions for cardiovascular risk assessment.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:18Lipids: Dietary Sources and Requirements
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...